B. Keymeulen et al., THE EFFECT OF INSULIN-TREATMENT ON FUNCTION OF INTRAPORTALLY GRAFTED ISLETS IN STREPTOZOTOCIN-DIABETIC RATS, Transplantation, 56(1), 1993, pp. 60-64
This study examines whether a 10-week period of daily insulin injectio
ns following intraportal islet transplantation improves the metabolic
state in streptozotocin-diabetic recipients of a suboptimal number of
beta cells. In recipients receiving 0.5 million beta cells, insulin tr
eatment increased the number of animals with normal basal glycemia (fr
om 2/6 to 7/8) and normal serum fructosamine (from 1/6 to 6/8). Howeve
r, during the four weeks following a 10-week insulin regimen, this ben
eficial effect was lost and no differences were noticed in glucose tol
erance curves and hepatic insulin reserves of insulin-treated and untr
eated recipients. In recipients receiving 1.1 million beta cells, admi
nistration of insulin did not influence the number of animals with nor
mal basal glycemia (7/7 in both groups) or with normal serum fructosam
ine (5/7 versus 4 to 6/7) during the period of treatment or during the
subsequent 4 weeks; prior insulin treatment did not improve glucose t
olerance curves but reduced the hepatic insulin reserves by one-third.
It is concluded that insulin injections can improve the metabolic sta
te in recipients of an insufficient islet mass but do not enhance the
metabolic capacity or insulin reserves of a hepatic islet implant. The
reduced hepatic insulin content in one group of insulin-treated recip
ients raises the possibility that supplements of insulin injections re
duce the size of grafted insulin reserves.